70/100BJohnson & Johnson company profile
- CEO
- Joaquin Duato
- Employees
- 141,700
- Headquarters
- One Johnson & Johnson Plaza, New Brunswick, NJ 08933, US
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- IPO date
- 2 Jan 1962
- Stock exchange
- NYSE
- ISIN
- US4781601046
Website:jnj.com
About the company
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Employees
Johnson & Johnson had about 138,200 employees at the end of fiscal year 2025 (28 December 2025), by its annual report. That is 0.1% more than a year before.
Employees at each fiscal year end, as the company reports them in its annual report (10-K); revenue and net income per employee are the fiscal year's over that count.
Who owns Johnson & Johnson
Institutions such as funds, banks and insurers held 74.5% of Johnson & Johnson's shares on 30 June 2026, 4,814 of them reporting holdings to the SEC; the rest is held by individual investors and other shareholders.
Shares free to trade
Closely held shares belong to insiders, founders and owners of more than 5%, and seldom change hands. The free float is the rest: the shares anyone can buy and sell.
Common questions about Johnson & Johnson
Source: Financial Modeling PrepVerified against SEC filings